Mutational Signatures of a Combined Environmental Exposure: Arsenic and Ultraviolet Radiation
Mutational Signatures of a Combined Environmental Exposure: Arsenic and Ultraviolet Radiation
批准号:
10844717
负责人:
LAURIE G HUDSON
金额:
$50.33万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-04-06 至 2025-01-31
关键词:
AddressAgreementAnimal ModelArsenicArsenitesBiochemicalCancer EtiologyCarcinogensCell Culture TechniquesCell modelCellsCharacteristicsChronicComplexComputer AnalysisDNA DamageDNA RepairDNA Repair GeneDNA Sequence AlterationDataDefectDevelopmentEnvironmentEnvironmental ExposureEnvironmental Risk FactorEpidemiologyExonsExposure toHistopathologyHumanInduced MutationInterventionIntronsMalignant NeoplasmsMalignant neoplasm of lungMetal exposureMetalsMolecularMotivationMusMutagenesisMutationMutation AnalysisMutation SpectraNucleotide Excision RepairNucleotide Excision Repair InhibitionOutcomeOutcome StudyPatternPersonsPositioning AttributePredictive ValuePrevention strategyProcessPublishingResearchResearch DesignResearch PersonnelRiskSafetySamplingSkinSkin CancerSkin CarcinogenesisSomatic MutationTobacco smokeTranscription-Coupled RepairUV inducedUV induced DNA damageUltraviolet RaysWorld Health OrganizationXPA geneZincZinc FingersZinc supplementationcancer epidemiologycarcinogenesiscarcinogenicitycombinatorialdrinking watergenome sequencingin vivoinsightkeratinocytelifestyle factorsmeternew technologynext generation sequencingpredictive modelingrepairedskin squamous cell carcinomatooltumorwhole genomexeroderma pigmentosum group A complementing protein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Over 200 million people worldwide are chronically exposed to arsenic in drinking water at concentrations above
the EPA or World Health Organization safety standard. There is strong experimental and epidemiological
evidence that low levels of arsenic in combination with other environmental insults such as ultraviolet radiation
(UVR) increases carcinogenesis, suggesting arsenic is a co-carcinogen in humans. However, little is known
about the molecular mechanisms of arsenic co-carcinogenesis or effective strategies for prevention of arsenic-
augmented cancers. Recent advances in analysis of next generation sequencing have given rise to powerful
tools to define distinct mutational signatures in tumors that identify specific defects in DNA repair processes or
carcinogenic exposures as part of cancer etiology. In current proposed study we will apply this new technology
to advance our understanding of arsenic as a co-carcinogen when combined with the DNA damaging UVR. We
have published an extensive body of work demonstrating that arsenic interferes with the zinc finger motifs of
select DNA repair proteins leading to decreased repair capacity and increased DNA damage and mutations
that are alleviated by zinc. A preliminary mutation pattern analysis of normal human keratinocytes exposed to
0.1 µM arsenite, UVR, or both revealed that this low concentration of arsenite was sufficient to enhance UVR-
induced C>T mutations and zinc supplement reduced C>T mutations suggesting a potential intervention.
Furthermore, the mutational signatures generated by UVR and arsenite differ from those of UVR alone,
indicating that arsenite modifies the mutation spectrum rather than simply amplify the UVR signature. Based on
our published and preliminary findings, we hypothesize that arsenic enhances UVR-induced skin
carcinogenesis by disrupting the zinc finger function of the key DNA repair protein XPA, which in turn, results in
deficient nucleotide excision repair leading to greater accumulation of somatic mutations. In Aim 1, we will
determine whether exposure to arsenic, UVR or both generates unique mutational signatures and the impact of
zinc on identified signatures using whole genome sequencing and advanced computational approaches
developed by co-investigator Dr. Alexandrov. Aim 2 will investigate the molecular mechanism of C>T mutation
enhancement by arsenic through transcription-coupled nucleotide excision repair inhibition using both
biochemical approaches and computational analysis of whole genome sequencing data. In Aim 3, we will use a
proven animal model of UVR-induced skin carcinogenesis to define in vivo mutational signatures from UVR-
induced tumors with or without arsenic and the impact of zinc on the mutation signature. The outcomes from
our rigorously designed studies are expected to provide the first experimental definition of a metal-induced
mutation signature and the first analysis of mutational signatures generated by combination exposures to two
important and relevant environmental insults, as well as the insights into mechanisms by which arsenic
enhances UVR-induced carcinogenesis and how zinc confers protection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pilot Project Core
-
批准号:10393303
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2022
-
负责人:LAURIE G HUDSON
-
依托单位:
Pilot Project Core
-
批准号:10689705
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2022
-
负责人:LAURIE G HUDSON
-
依托单位:
Illuminating the functions and translational potential of CDC42BP/MRCK kinases in ovarian cancer
-
批准号:10216717
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2021
-
负责人:LAURIE G HUDSON
-
依托单位:
Mutational Signatures of a Combined Environmental Exposure: Arsenic and Ultraviolet Radiation
-
批准号:10330581
-
项目类别:
-
资助金额:$50.85万
-
财政年份:2020
-
负责人:LAURIE G HUDSON
-
依托单位:
Biomarkers and mechanisms of metal and mixed metal exposures
-
批准号:10707512
-
项目类别:
-
资助金额:$32.6万
-
财政年份:2017
-
负责人:LAURIE G HUDSON
-
依托单位:
Biomarkers and mechanisms of metal and mixed metal exposures
-
批准号:10353202
-
项目类别:
-
资助金额:$35.08万
-
财政年份:2017
-
负责人:LAURIE G HUDSON
-
依托单位:
Zinc Chemoprevention of Arsenic Co-Carcinogenesis
-
批准号:8762020
-
项目类别:
-
资助金额:$31.33万
-
财政年份:2014
-
负责人:LAURIE G HUDSON
-
依托单位:
Zinc Chemoprevention of Arsenic Co-Carcinogenesis
-
批准号:9325454
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2014
-
负责人:LAURIE G HUDSON
-
依托单位:
Arsenic co-carcinogenesis with UVR: nitrosation and oxidation of target proteins
-
批准号:8856568
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2012
-
负责人:LAURIE G HUDSON
-
依托单位:
Capitalizing on NSAID enantiomer selectivity for cancer prevention and therapy(PQ
-
批准号:8625502
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2012
-
负责人:LAURIE G HUDSON
-
依托单位:
Arsenic co-carcinogenesis with UVR: nitrosation and oxidation of target proteins
-
批准号:8369694
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2012
-
负责人:LAURIE G HUDSON
-
依托单位:
Capitalizing on NSAID enantiomer selectivity for cancer prevention and therapy(PQ
-
批准号:8519391
-
项目类别:
-
资助金额:$15.42万
-
财政年份:2012
-
负责人:LAURIE G HUDSON
-
依托单位:
Arsenic co-carcinogenesis with UVR: nitrosation and oxidation of target proteins
-
批准号:8537458
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2012
-
负责人:LAURIE G HUDSON
-
依托单位:
Capitalizing on NSAID enantiomer selectivity for cancer prevention and therapy(PQ
-
批准号:8383195
-
项目类别:
-
资助金额:$20.91万
-
财政年份:2012
-
负责人:LAURIE G HUDSON
-
依托单位:
Predicting Novel Arsenic Targets in DNA Repair Pathways
-
批准号:8280519
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2012
-
负责人:LAURIE G HUDSON
-
依托单位:
Arsenic co-carcinogenesis with UVR: nitrosation and oxidation of target proteins
-
批准号:8681443
-
项目类别:
-
资助金额:$33.64万
-
财政年份:2012
-
负责人:LAURIE G HUDSON
-
依托单位:
Arsenic co-carcinogenesis with UVR: nitrosation and oxidation of target proteins
-
批准号:9066671
-
项目类别:
-
资助金额:$71.37万
-
财政年份:2012
-
负责人:LAURIE G HUDSON
-
依托单位:
Predicting Novel Arsenic Targets in DNA Repair Pathways
-
批准号:8431343
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2012
-
负责人:LAURIE G HUDSON
-
依托单位:
Arsenic-enhanced skin carcinogenesis by UV radiation
-
批准号:7814459
-
项目类别:
-
资助金额:$62.91万
-
财政年份:2009
-
负责人:LAURIE G HUDSON
-
依托单位:
The role of Slug in cutaneous reepithelialization
-
批准号:7658899
-
项目类别:
-
资助金额:$28.47万
-
财政年份:2007
-
负责人:LAURIE G HUDSON
-
依托单位:
海外基金